ALXO ALX Oncology Holdings Inc. - Common Stock
$2,08
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$1–$3
69% of range
Analystenbewertung
BUY
13 analysts
Kursziel
$5
+121% upside
P/E (TTM)
-2.8
ROE
-225.0%
Nettogewinnmarge
—
ALXO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.08
Marktkapitalisierung
$287M
P/E (TTM)
-2.8
EPS (TTM)
$-1.90
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-225.0%
Verschuldungsgrad
0.4
52W-Spanne
$1 – $3
ALXO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2018-12-31
→
2022-12-31
EPS
$-1.90
2020-12-31
→
2025-12-31
Freier Cashflow
$-84M
2020-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ALXO
Peer-Median
P/E (TTM)
-2.8
—
P/S (TTM) (K/V (TTM))
77.0
50.2
P/B (K/B)
11.1
1.0
EV / EBITDA
-2.4
—
Price / FCF (Kurs / FCF)
-3.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ALXO
Peer-Median
ROA
-98.3%
-40.4%
ROE
-225.0%
-43.7%
ROIC
-291.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ALXO
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.4
0.0
Current Ratio (Liquiditätsgrad)
2.1
7.3
Quick Ratio
1.8
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ALXO
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ALXO
Peer-Median
ALXO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
13 Analysten
- Starker Kauf 3 23,1%
- Kauf 8 61,5%
- Halten 2 15,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-17
Median
$4.00
Mittelwert
$4.60
← Unter allen Zielen
$2.08
Tief
$4.00
Hoch
$6.00
Median-Ziel
$4.00
+92,3%
Mittelwert-Ziel
$4.60
+121,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.12 | $-0.15 | 0.03% |
| 31. März 2026 | $-0.15 | $-0.20 | 0.05% |
| 31. Dezember 2025 | $-0.37 | $-0.37 | -0.00% |
| 30. September 2025 | $-0.41 | $-0.37 | -0.04% |
| 30. Juni 2025 | $-0.43 | $-0.46 | 0.03% |
| 31. März 2025 | $-0.58 | $-0.47 | -0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| SRZN | — | — | — | — | — | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| ZSQR | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | $1M | $5M | |
| R&D Expense | $77M | $116M | $142M | $98M | $60M | $29M | $16M | |
| SG&A Expense | $24M | $26M | $28M | $29M | $23M | $15M | $3M | |
| Operating Expenses | $104M | $142M | $170M | $127M | $84M | $45M | $24M | |
| Operating Income | $-104M | $-142M | $-170M | $-127M | $-84M | $-44M | $-19M | |
| Interest Expense | $2M | $2M | $2M | $238.0K | $13.0K | · | · | |
| Interest Income | $4M | $9M | $11M | $4M | $91.0K | · | · | |
| Other Non-op | $-36.0K | $-20.0K | $389.0K | $-22.0K | $-7.0K | $-1M | $-5.0K | |
| Pretax Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-45M | $-19M | |
| Income Tax | $0 | $0 | $0 | $64.0K | $-21.0K | $241.0K | $34.0K | |
| Net Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | $-19M | |
| EPS (Basic) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| Shares (Basic) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | 3,076,461 | |
| Shares (Diluted) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | · | |
| EBITDA | $-103M | $-142M | $-169M | $-127M | $-84M | $-43M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $22M | $49M | $364M | $434M | $9M | |
| Short-term Investments | $28M | $110M | $160M | $217M | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $5M | $3M | $2M | $256.0K | |
| Other Current Assets | $20.0K | $27.0K | $439.0K | · | · | · | · | |
| Current Assets | $51M | $134M | $189M | $271M | $367M | $436M | $10M | |
| PP&E (Net) | $1M | $3M | $4M | $4M | $897.0K | $52.0K | $860.0K | |
| PP&E (Gross) | $3M | $5M | $5M | $4M | $960.0K | $77.0K | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $403.0K | $63.0K | $25.0K | $1M | |
| Other Non-current Assets | $4M | $7M | $15M | $15M | $12M | $10.0K | $7.0K | |
| Total Assets | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Accounts Payable | $5M | $4M | $9M | $8M | $4M | $4.0K | $4M | |
| Current Liabilities | $25M | $18M | $36M | $28M | $15M | $6M | $5M | |
| Capital Leases | $3M | $3M | $4M | $5M | $2M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $5M | $2M | $5.0K | $547.0K | |
| Total Liabilities | $33M | $34M | $53M | $43M | $17M | $6M | $11M | |
| Long-term Debt | $10M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | |
| Retained Earnings | $-723M | $-621M | $-486M | $-325M | $-202M | $-119M | $-73M | |
| AOCI | $28.0K | $275.0K | $256.0K | $-845.0K | · | · | · | |
| Stockholders' Equity | $26M | $114M | $190M | $263M | $363M | $430M | $-71M | |
| Liabilities + Equity | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Shares Outstanding | 54,388,022 | 53,052,912 | 49,951,989 | 40,861,386 | 40,587,067 | 39,844,522 | 3,166,946 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | |
| Stock-based Comp | $13M | $27M | $26M | $24M | $14M | $5M | $297.0K | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $4M | $-15M | $3M | $10M | $1M | $2M | · | |
| Operating Cash Flow | $-84M | $-122M | $-130M | $-89M | $-68M | $-38M | $-14M | |
| CapEx | $212.0K | $447.0K | $1M | $1M | $666.0K | $31.0K | $353.0K | |
| Investing Cash Flow | $83M | $86M | $45M | $-235M | $-5M | $610.0K | $-353.0K | |
| Stock Issued | $2M | $30M | · | · | · | $368M | · | |
| Net Stock Activity | $2M | $30M | · | · | · | $368M | · | |
| Financing Cash Flow | $362.0K | $31M | $59M | $10M | $2M | $463M | $15M | |
| Free Cash Flow | $-84M | $-122M | $-132M | $-91M | $-69M | $-38M | · | |
| Levered FCF | $-86M | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -3694.0% | · | |
| Net Margin | · | · | · | · | · | -3869.7% | · | |
| Pretax Margin | · | · | · | · | · | -3849.3% | · | |
| EBITDA Margin | · | · | · | · | · | -3676.9% | · | |
| ROA | -98.3% | -69.1% | -58.6% | -36.0% | -20.4% | -20.5% | · | |
| ROE | -225.0% | -107.7% | -89.7% | -44.9% | -22.3% | -13.4% | · | |
| ROIC | -291.1% | · | · | -46.7% | -23.0% | -10.2% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 | 70.3 | · | |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 | 70.0 | · | |
| Debt / Equity | 0.4 | 0.1 | 0.1 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Interest Coverage | -64.9 | -82.4 | -108.8 | · | · | · | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | 0.0 | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $4M | $0 | $0 | $1M | · | |
| Net Income TTM | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | · | |
| Market Cap | $61M | $89M | $744M | $461M | $872M | $3.43B | · | |
| Enterprise Value | $26M | $-29M | $571M | $204M | · | · | · | |
| P/E | -0.6 | -0.6 | -4.0 | -3.7 | -10.4 | -31.2 | · | |
| P/S | 16.5 | 23.7 | 199.2 | · | · | 2905.8 | · | |
| P/B | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Tangible Book | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Cash Flow | -0.7 | -0.7 | -5.7 | -5.2 | -12.8 | -89.7 | · | |
| P / FCF | -0.7 | -0.7 | -5.7 | -5.1 | -12.7 | -89.6 | · | |
| EV / EBITDA | -0.3 | 0.2 | -3.4 | -1.6 | · | · | · | |
| EV / FCF | -0.3 | 0.2 | -4.3 | -2.2 | · | · | · | |
| EV / Revenue | 7.1 | -7.8 | 152.9 | · | · | · | · | |
| Earnings Yield | -168.1% | -154.5% | -25.1% | -26.9% | -9.6% | -3.2% | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $14M | $18M | $17M | $18M | $24M | $24M | $26M | $35M | $32M | $42M | $46M | $29M | $25M | $25M | $29M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $7M | $6M | $6M | $8M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $18M | $19M | $23M | $23M | $27M | $32M | $31M | $33M | $42M | $38M | $48M | $53M | $37M | $32M | $32M | $37M | |
| Operating Income | $-18M | $-19M | $-23M | $-23M | $-27M | $-32M | $-31M | $-33M | $-42M | $-38M | $-48M | $-53M | $-37M | $-32M | $-32M | $-37M | |
| Interest Expense | $285.0K | $331.0K | $383.0K | $408.0K | $405.0K | $406.0K | $427.0K | $446.0K | $429.0K | $427.0K | $415.0K | $391.0K | $372.0K | $387.0K | $231.0K | $2.0K | |
| Interest Income | $2M | $1M | $573.0K | $802.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Other Non-op | $-257.0K | $188.0K | $-17.0K | $-6.0K | $-2.0K | $-11.0K | $-1.0K | $3.0K | $-8.0K | $-14.0K | $-29.0K | $-1.0K | $324.0K | $95.0K | $-2.0K | $-7.0K | |
| Net Income | $-18M | $-18M | $-23M | $-22M | $-26M | $-31M | $-29M | $-31M | $-39M | $-36M | $-45M | $-51M | $-34M | $-30M | $-31M | $-35M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | |
| Shares (Basic) | 135,639,684 | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | |
| Shares (Diluted) | 135,639,684 | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | |
| EBITDA | $-18M | $-19M | · | $-23M | $-27M | $-32M | · | $-33M | $-42M | $-38M | · | $-53M | $-37M | $-32M | · | $-37M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $32M | $16M | $23M | $19M | $21M | $18M | $16M | $16M | $14M | $22M | $20M | $38M | $63M | $49M | $49M | |
| Short-term Investments | $116M | $108M | $28M | $37M | $60M | $77M | $110M | $132M | $141M | $143M | · | $170M | $175M | $165M | · | $236M | |
| Prepaid Expense | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $12M | $10M | · | $9M | $7M | $5M | · | $6M | |
| Other Current Assets | $542.0K | $25.0K | $20.0K | · | $4.0K | · | $27.0K | $1M | $315.0K | · | · | · | · | · | · | · | |
| Current Assets | $143M | $146M | $51M | $67M | $85M | $103M | $134M | $156M | $169M | $168M | · | $199M | $220M | $233M | · | $291M | |
| PP&E (Net) | $166.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $2M | |
| PP&E (Gross) | $1M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $3M | |
| Accum. Depreciation | $938.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $823.0K | $616.0K | · | $300.0K | |
| Other Non-current Assets | $2M | $3M | $4M | $9M | $4M | $7M | $7M | $13M | $13M | $14M | · | $11M | $11M | $13M | · | $16M | |
| Total Assets | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | |
| Accounts Payable | $3M | $4M | $5M | $7M | $5M | $4M | $4M | $8M | $8M | $6M | · | $13M | $4M | $10M | · | $6M | |
| Current Liabilities | $15M | $20M | $25M | $28M | $19M | $19M | $18M | $32M | $38M | $32M | · | $35M | $18M | $22M | · | $25M | |
| Capital Leases | $0 | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $152.0K | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | · | $7M | $6M | $6M | · | $5M | |
| Total Liabilities | $25M | $27M | $33M | $38M | $31M | $33M | $34M | $49M | $55M | $48M | · | $51M | $33M | $38M | · | $31M | |
| Long-term Debt | $10M | $9M | $10M | $11M | $11M | $11M | $10M | $11M | $11M | $11M | · | $11M | $11M | $11M | · | · | |
| Total Debt | $10M | $9M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | $10M | $10M | $9M | · | · | |
| Common Stock | $138.0K | $135.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $52.0K | $50.0K | · | $41.0K | $41.0K | $41.0K | · | $41.0K | |
| Retained Earnings | $-759M | $-741M | $-723M | $-700M | $-678M | $-652M | $-621M | $-592M | $-561M | $-522M | · | $-441M | $-390M | $-356M | · | $-295M | |
| AOCI | $-224.0K | $-245.0K | $28.0K | $43.0K | $36.0K | $118.0K | $275.0K | $563.0K | $-73.0K | $28.0K | · | $-226.0K | $-312.0K | $-88.0K | · | $-2M | |
| Stockholders' Equity | $136M | $151M | $26M | $45M | $64M | $88M | $114M | $137M | $159M | $164M | $190M | $169M | $213M | $240M | $263M | $287M | |
| Liabilities + Equity | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | |
| Shares Outstanding | 138,216,247 | 134,540,741 | 54,388,022 | 53,577,566 | 53,506,777 | 53,384,145 | 53,052,912 | 52,743,104 | 52,452,749 | 50,277,193 | · | 41,151,819 | 40,992,179 | 40,863,049 | · | 40,748,290 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $86.0K | $150.0K | $151.0K | $153.0K | $191.0K | $211.0K | $214.0K | $224.0K | $220.0K | $214.0K | $207.0K | $209.0K | $207.0K | $213.0K | $105.0K | $95.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-cash | · | $-3M | · | · | · | $664.0K | · | · | · | $-10M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-16M | $-19M | $-19M | $-17M | $-23M | $-25M | $-32M | $-25M | $-27M | $-38M | $-40M | $-31M | $-32M | $-28M | $-21M | $-31M | |
| CapEx | $17.0K | $50.0K | $49.0K | $56.0K | $47.0K | $60.0K | $60.0K | $149.0K | $90.0K | $148.0K | $148.0K | $-1M | $2M | $690.0K | $389.0K | $192.0K | |
| Investing Cash Flow | $7M | $-105M | $11M | $21M | $22M | $28M | $33M | $26M | $907.0K | $26M | $-17M | $13M | $6M | $42M | $11M | $14M | |
| Stock Issued | $0 | $11.0K | $1M | $0 | $0 | $372.0K | $359.0K | $75.0K | $26M | $3M | · | · | · | · | · | · | |
| Net Stock Activity | · | $11.0K | · | · | · | $372.0K | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $137.0K | $140M | $678.0K | $-159.0K | $-222.0K | $65.0K | $328.0K | $251.0K | $27M | $3M | $59M | $-111.0K | $343.0K | $-107.0K | $9M | $-136.0K | |
| Free Cash Flow | · | $-19M | · | · | · | $-25M | · | · | · | $-38M | · | · | · | $-29M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.0% | -12.0% | · | -16.5% | -16.7% | -18.4% | · | -15.1% | -17.1% | -14.5% | · | -19.0% | -11.5% | -9.4% | · | -9.8% | |
| ROE | -17.9% | -15.0% | · | -24.4% | -23.2% | -24.4% | · | -20.1% | -21.2% | -17.6% | · | -22.4% | -12.9% | -10.3% | · | -10.5% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 7.2 | · | 2.4 | 4.5 | 5.5 | · | 4.8 | 4.4 | 5.2 | · | 5.7 | 12.5 | 10.6 | · | 11.5 | |
| Quick Ratio | 9.4 | 7.0 | · | 2.2 | 4.2 | 5.2 | · | 4.6 | 4.1 | 4.9 | · | 5.4 | 12.1 | 10.4 | · | 11.3 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | |
| Interest Coverage | -63.3 | -57.3 | · | -55.2 | -65.8 | -78.4 | · | -73.0 | -96.8 | -88.4 | · | -136.3 | -98.9 | -83.2 | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Net Income TTM | $-84M | $-97M | · | $-110M | $-127M | $-136M | · | $-157M | $-160M | $-151M | · | $-151M | $-133M | $-123M | · | $-117M | |
| Market Cap | $286M | $270M | · | $98M | $22M | $33M | · | $96M | $316M | $561M | · | $198M | $308M | $185M | · | $390M | |
| Enterprise Value | $158M | $138M | · | $48M | $-47M | $-55M | · | $-43M | $169M | $413M | · | $17M | $105M | $-34M | · | · | |
| P/E | -1.7 | -1.2 | · | -0.9 | -0.2 | -0.2 | · | -0.6 | -1.7 | -3.2 | · | -1.3 | -2.3 | -1.5 | · | -3.3 | |
| P/S | 76.6 | 72.3 | · | 26.3 | 5.9 | 8.9 | · | 25.7 | 84.7 | 150.2 | · | 52.9 | 82.5 | 49.5 | · | 104.5 | |
| P/B | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | |
| P / Tangible Book | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | |
| P / Cash Flow | · | -14.5 | · | · | · | -1.3 | · | · | · | -14.8 | · | · | · | -6.6 | · | · | |
| P / FCF | · | -14.4 | · | · | · | -1.3 | · | · | · | -14.7 | · | · | · | -6.5 | · | · | |
| EV / EBITDA | -8.7 | -7.3 | · | -2.1 | 1.8 | 1.7 | · | 1.3 | -4.1 | -11.0 | · | -0.3 | -2.8 | 1.1 | · | · | |
| EV / FCF | · | -7.4 | · | · | · | 2.2 | · | · | · | -10.8 | · | · | · | 1.2 | · | · | |
| EV / Revenue | 42.2 | 37.0 | · | 12.7 | -12.6 | -14.6 | · | -11.5 | 45.4 | 110.6 | · | 4.6 | 28.0 | -9.1 | · | · | |
| Earnings Yield | -58.0% | -82.3% | · | -112.6% | -580.7% | -422.1% | · | -180.8% | -58.9% | -31.7% | · | -76.9% | -43.4% | -66.8% | · | -30.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | $0 | $0 |
| Nettoergebnis | $-102M | $-135M | $-161M | $-123M | $-83M |
| Verwässerte EPS | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.1 | 0.1 | 0.0 | — |
| Liquiditätsgrad | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-84M | $-122M | $-132M | $-91M | $-69M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 102 Einreicher · $188.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 43 (+23 vs. Vorquartal) | 11 (+1 vs. Vorquartal) | 21 (+3 vs. Vorquartal) | 13 (0 vs. Vorquartal) | +11.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $26.934.527 | 13.011.849 | 14,32% | Aktien |
| venBio Partners LLC | $26.671.201 | 12.884.638 | 14,18% | Aktien |
| Redmile Group, LLC | $15.302.483 | 7.392.504 | 8,13% | Aktien |
| Blackstone Inc. | $13.648.634 | 6.593.543 | 7,26% | Aktien |
| Driehaus Capital Management LLC | $12.472.247 | 6.025.240 | 6,63% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $11.891.647 | 5.744.757 | 6,32% | Aktien |
| TCG Crossover Management, LLC | $11.706.858 | 5.655.487 | 6,22% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.295.013 | 4.973.436 | 5,47% | Aktien |
| Vivo Capital, LLC | $6.592.356 | 3.184.713 | 3,50% | Aktien |
| 5AM Venture Management, LLC | $6.328.663 | 3.057.325 | 3,36% | Aktien |
| Almitas Capital LLC | $6.082.552 | 2.938.431 | 3,23% | Aktien |
| ORBIMED ADVISORS LLC | $5.933.150 | 2.866.256 | 3,15% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.900.930 | 2.367.377 | 2,61% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.508.824 | 2.178.176 | 2,40% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.195.240 | 1.543.594 | 1,70% | Aktien |
| STATE STREET CORP | $3.102.733 | 1.498.905 | 1,65% | Aktien |
| Ensign Peak Advisors, Inc | $1.677.315 | 810.297 | 0,89% | Aktien |
| VANGUARD GROUP INC | $1.607.644 | 1.422.694 | 0,85% | Aktien |
| Nantahala Capital Management, LLC | $1.552.500 | 750.000 | 0,83% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.550.904 | 749.229 | 0,82% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.539.026 | 743.491 | 0,82% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.249.860 | 603.797 | 0,66% | Aktien |
| ADAR1 Capital Management, LLC | $1.104.676 | 533.660 | 0,59% | Aktien |
| UBS Group AG | $894.341 | 432.049 | 0,48% | Aktien |
| TWO SIGMA ADVISERS, LP | $802.752 | 710.400 | 0,43% | Aktien |
| GOLDMAN SACHS GROUP INC | $644.037 | 311.129 | 0,34% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $499.104 | 241.113 | 0,27% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $467.969 | 226.072 | 0,25% | Aktien |
| Atom Investors LP | $454.121 | 219.382 | 0,24% | Aktien |
| IEQ CAPITAL, LLC | $363.041 | 175.382 | 0,19% | Aktien |
| Nuveen, LLC | $297.345 | 143.645 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $254.935 | 123.157 | 0,14% | Aktien |
| RHUMBLINE ADVISERS | $223.350 | 107.902 | 0,12% | Aktien |
| WELLS FARGO & COMPANY/MN | $203.742 | 98.426 | 0,11% | Aktien |
| Verdad Advisers, LP | $170.154 | 82.200 | 0,09% | Aktien |
| BANK OF AMERICA CORP /DE/ | $157.386 | 76.032 | 0,08% | Aktien |
| Graham Capital Management, L.P. | $154.879 | 74.821 | 0,08% | Aktien |
| BlackRock, Inc. | $146.579 | 70.811 | 0,08% | Aktien |
| XTX Topco Ltd | $144.190 | 69.657 | 0,08% | Aktien |
| MetLife Investment Management, LLC | $134.465 | 64.959 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $129.176 | 62.404 | 0,07% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $102.842 | 49.682 | 0,05% | Aktien |
| Nuveen Asset Management, LLC | $101.528 | 60.795 | 0,05% | Aktien |
| Squarepoint Ops LLC | $97.019 | 46.869 | 0,05% | Aktien |
| CITIGROUP INC | $91.925 | 44.408 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $89.089 | 43.038 | 0,05% | Aktien |
| Invesco Ltd. | $89.064 | 43.026 | 0,05% | Aktien |
| AXQ CAPITAL, LP | $83.945 | 40.553 | 0,04% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $80.773 | 38.011 | 0,04% | Aktien |
| CITADEL ADVISORS LLC | $74.934 | 36.200 | 0,04% | Kaufoption |
| NEW YORK STATE COMMON RETIREMENT FUND | $68.517 | 33.100 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $65.872 | 31.822 | 0,04% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $64.164 | 30.997 | 0,03% | Aktien |
| BARCLAYS PLC | $52.963 | 25.586 | 0,03% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $52.812 | 26.340 | 0,03% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $52.799 | 25.507 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51.336 | 24.800 | 0,03% | Kaufoption |
| HC Advisors, LLC | $47.403 | 22.900 | 0,03% | Aktien |
| Callan Family Office, LLC | $46.407 | 22.419 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $44.424 | 21.461 | 0,02% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $44.368 | 21.434 | 0,02% | Aktien |
| CAXTON CORP | $43.358 | 20.946 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $40.208 | 19.424 | 0,02% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $38.190 | 18.451 | 0,02% | Aktien |
| Bronte Capital Management Pty Ltd. | $37.457 | 18.095 | 0,02% | Aktien |
| JSF Financial, LLC | $36.225 | 17.500 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $34.942 | 16.880 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $34.395 | 16.616 | 0,02% | Aktien |
| PRUDENTIAL FINANCIAL INC | $33.917 | 16.385 | 0,02% | Aktien |
| MARSHALL WACE, LLP | $32.317 | 15.612 | 0,02% | Aktien |
| MONETA GROUP INVESTMENT ADVISORS LLC | $31.456 | 15.196 | 0,02% | Aktien |
| ProShare Advisors LLC | $29.238 | 14.125 | 0,02% | Aktien |
| Lido Advisors, LLC | $27.365 | 13.220 | 0,01% | Aktien |
| FMR LLC | $27.183 | 13.132 | 0,01% | Aktien |
| Abel Hall, LLC | $26.353 | 12.731 | 0,01% | Aktien |
| China Universal Asset Management Co., Ltd. | $25.875 | 12.500 | 0,01% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $25.449 | 13.907 | 0,01% | Aktien |
| Beacon Pointe Advisors, LLC | $25.063 | 12.500 | 0,01% | Aktien |
| Legal & General Group Plc | $21.700 | 10.483 | 0,01% | Aktien |
| HSBC HOLDINGS PLC | $21.574 | 10.105 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $21.522 | 10.397 | 0,01% | Aktien |
| XPONANCE LLC | $21.071 | 10.179 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $20.269 | 9.792 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $17.859 | 8.628 | 0,01% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $16.943 | 8.185 | 0,01% | Aktien |
| Cubist Systematic Strategies, LLC | $14.687 | 8.025 | 0,01% | Aktien |
| ROYAL BANK OF CANADA | $7.000 | 3.494 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $4.324 | 2.089 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $2.713 | 1.313.490 | 0,00% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $2.289 | 1.106 | 0,00% | Aktien |
| Bradley & Co. Private Wealth Management, LLC | $2.070 | 1.000 | 0,00% | Aktien |
| EverSource Wealth Advisors, LLC | $1.873 | 905 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $856 | 413.545 | 0,00% | Aktien |
| Sterling Capital Management LLC | $785 | 379 | 0,00% | Aktien |
| Integrated Wealth Concepts LLC | $270 | 130 | 0,00% | Aktien |
| MORGAN STANLEY | $242 | 117 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $218 | 99 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $207 | 100 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $186 | 89.779 | 0,00% | Aktien |
| CWM, LLC | $130 | 65 | 0,00% | Aktien |
Unternehmensinsider 19 Insider · 10 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | 17. August 2026 S | 294.379 | 2 | 3 | $66.858 |
| Harish Shantharam | Chief Financial Officer | 26. Januar 2026 A | 75.000 | 1 | 0 | $58.500 |
| Peter S Garcia | Chief Financial Officer | 29. Dezember 2023 S | 85.348 | 0 | 0 | $0 |
| Jaume Pons | President & CSO | 29. Dezember 2023 S | 618.359 | 0 | 0 | $0 |
| Shelly Pinto | SVP, FINANCE AND CAO | 17. August 2026 S | 87.828 | 0 | 6 | $-11.961 |
| Jeff E. Knight | Chief Dev & Operating Officer | 16. April 2026 A | — | 0 | 0 | $0 |
| Barbara Klencke | Chief Medical Officer | 16. April 2026 A | — | 0 | 0 | $0 |
| Sophia Randolph | Chief Medical Officer | 29. Dezember 2023 S | 312.349 | 0 | 0 | $0 |
| Nathan Caffo | Chief Business Officer | 21. Juli 2020 C | 11.254 | 0 | 0 | $0 |
| Steffen Pietzke | VP Fin & Chief Acct Officer | 21. Juli 2020 P | 3.000 | 0 | 0 | $0 |
| Daniel J. Curran | Direktor | 20. Januar 2026 A | — | 0 | 0 | $0 |
| Alan B. Sandler | Direktor | 20. Januar 2026 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | Direktor | 20. Januar 2026 A | 3.000 | 0 | 0 | $0 |
| Chris H Takimoto | Direktor | 20. Januar 2026 A | — | 0 | 0 | $0 |
| Scott J. Garland | Direktor | 20. Januar 2026 A | — | 0 | 0 | $0 |
| Itziar Canamasas | Direktor | 20. Juni 2023 A | — | 0 | 0 | $0 |
| Jack Nielsen | Direktor | 20. Juni 2023 A | — | 0 | 0 | $0 |
| Graham Walmsley | Direktor | 11. Juni 2021 A | 995.000 | 0 | 0 | $0 |
| Corey S Goodman | — | 2. Februar 2026 P | 8.453.038 | 1 | 0 | $4.999.999 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| LSV Associates, LLC, Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates II, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., Michael A Carusi, Jean George, Henry A. Plain Jr | 27. Mai 2026 | 2,20% | Änderung | — | SEC |
| venBio Global Strategic Fund, L.P., venBio Global Strategic Fund II L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP II, L.P., venBio Global Strategic GP, Ltd., venBio Global Strategic GP II, Ltd., Adelman Robert J, GOODMAN COREY S ×2 Einreichungen | 4. Februar 2026 | 10,00% | Änderung | — | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., LSV Associates II, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×3 Einreichungen | 14. Februar 2024 | — | Erste Einreichung | — | SEC |
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities Fund I LP, Logos Opportunities GP LLC, Logos GP LLC ×2 Einreichungen | 15. Juni 2021 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 11 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,55% | 58.924 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,05% | 368.867 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 988.668 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 623.766 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 116.302 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 2.546.108 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 35.651 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 7.659 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.226.065 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.642.854 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.161 SH | 8. August 2026 | Täglich |